Noha Shawky

Dr. Noha Shawky


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
NSNoha Shawky
Noha Shawky
GSGeorge S. G. Shehatou
George S. G. Shehatou
GSGhada M. Suddek
Ghada M. Suddek
NGNariman M. Gameil
Nariman M. Gameil

6 April 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
Yhiya AmenYhiya Amen
Yhiya Amen
ASAsmaa Fady Sharif
Asmaa Fady Sharif
NSNoha Shawky
Noha Shawky
RARehab S. Abdelrahman
Rehab S. Abdelrahman
Michael WinkMichael Wink
Michael Wink
MSMansour Sobeh
Mansour Sobeh
Grape (Vitis vinifera) leaf extracts (GLEs) are known to be rich in phenolic compounds that exert potent antioxidant effects. Given the vulnerability of the liver to oxidative damage, antioxidants have been proposed as therapeutic agents and coadjuvant drugs to ameliorate liver pathologies. The current study was designed to characterize secondary metabolites and investigate the hepatoprotective effects of GLE and its underlying mechanisms. The secondary metabolites were profiled using HPLC–PDA–ESI-MS, and forty-five compounds were tentatively identified. In experimental in vivo design, liver injury was induced by oral administration of high doses of ethanol (EtOH) for 12 days to male Sprague Dawley rats that were split into five different groups. Blood samples and livers were then collected, and used for various biochemical, immunohistochemical, and histopathological analyses. Results showed that GLE-attenuated liver injury and promoted marked hepatic antioxidant effects, in addition to suppressing the increased heat-shock protein-70 expression. Moreover, GLE suppressed EtOH-induced expression of nuclear factor-κB (NF-κB) p65 subunit and proinflammatory cytokine tumor necrosis factor-α. Caspase-3 and survivin were enhanced by EtOH intake and suppressed by GLE intake. Finally, EtOH-induced histopathological changes in liver sections were markedly normalized by GLE. In conclusion, our results suggested that GLE interferes with NF-κB signaling and induces antioxidant effects, which both play a role in attenuating apoptosis and associated liver injury in a model of EtOH-induced liver damage in rats.

17 June 2022 in Kidney360
Verified
Journal Article
Closed access
PDF file
JRJane Reckelhoff
Jane Reckelhoff
NSNoha Shawky
Noha Shawky
DRDamian G. Romero
Damian G. Romero
LCLicy L. Yanes Cardozo
Licy L. Yanes Cardozo
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting approximately 10%. PCOS is diagnosed by the presence of at least two of these three criteria: hyperandrogenemia, oligo- or anovulation, and polycystic ovaries. The most common type (80%) of PCOS includes hyperandrogenemia. PCOS is also characterized by obesity or overweight (in 80% of US women with PCOS), insulin resistance with elevated plasma insulin but not necessarily hyperglycemia, dyslipidemia, proteinuria, and elevated BP. Although elevated compared with age-matched controls, BP may not reach levels considered treatable according to the current clinical hypertension guidelines. However, it is well known that elevated BP, even modestly so, increases the risk of cardiovascular disease. We have developed a model of hyperandrogenemia in rodents that mimics the characteristics of PCOS in women, with increases in body weight, insulin resistance, dyslipidemia, andproteinuria and elevated BP. This review discusses potential mechanisms responsible for the elevated BP in the adult and aging PCOS rat model that may be extrapolated to women with PCOS.

1 February 2019 in Biochemical Pharmacology
Verified
Journal Article
Closed access
MSMukund P. Srinivasan
Mukund P. Srinivasan
NSNoha Shawky
Noha Shawky
BKBhupendra S. Kaphalia
Bhupendra S. Kaphalia
MTMuthusamy Thangaraju
Muthusamy Thangaraju
LSLakshman Segar
Lakshman Segar

1 September 2023 in Hypertension
Verified
Journal Article
Closed access
NSNoha Shawky
Noha Shawky
JRJane Reckelhoff
Jane Reckelhoff
BABarbara T. Alexander
Barbara T. Alexander
LCLicy L. Yanes Cardozo
Licy L. Yanes Cardozo
Transgender individuals that undergo gender-affirming hormone therapy may experience discrimination in the health care setting with a lack of access to medical personnel competent in transgender medicine. Recent evidence suggests that gender-affirming hormone therapy is associated with an increased risk of cardiovascular diseases and cardiovascular risk factors. A recent statement from the American Heart Association reinforces the importance of cardiovascular-focused clinical management and the necessity for more research into the impact of gender-affirming hormone therapy. With this in mind, this review will highlight the known cardiovascular risk factors associated with gender-affirming hormone therapy and identify potential molecular mechanisms determined from the limited animal studies that explore the role of cross-sex steroids on cardiovascular risk. The lack of data in this understudied population requires future clinical and basic research studies to inform and educate clinicians and their transgender patient population to promote precision medicine for their care to improve their quality of life.

22 September 2023 in South African Journal of Botany
Verified
Journal Article
Closed access
ASAsmaa E. Sherif
Asmaa E. Sherif
Yhiya AmenYhiya Amen
Yhiya Amen
Michael WinkMichael Wink
Michael Wink
MSMansour Sobeh
Mansour Sobeh
RARehab S. Abdelrahman
Rehab S. Abdelrahman
NSNoha Shawky
Noha Shawky